Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia
Jorge J. Castillo, Shayna Sarosiek, Andrew R. Branagan, David Sermer, Catherine Flynn, Carly Leventoff, Megan Little, Timothy P. White, Kirsten Meid, Alexa G Canning, Maria Luisa Guerrera, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Christopher J. Patterson, Zachary R. Hunter, Steven P. Treon
Topics & Concepts
IbrutinibVenetoclaxWaldenstrom macroglobulinemiaMacroglobulinemiaMedicineLymphoplasmacytic LymphomaImmunologyLymphomaLeukemiaChronic lymphocytic leukemiaMultiple myelomaChronic Lymphocytic Leukemia Research